YS Biopharma Co, Performance
| YSDelisted Stock | 0.48 0.03 5.88% |
The firm owns a Beta (Systematic Risk) of 1.62, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, YS Biopharma will likely underperform. YS Biopharma Co, at this moment owns a risk of 0.0%. Please check out YS Biopharma Co, potential upside, day median price, and the relationship between the treynor ratio and accumulation distribution , to decide if YS Biopharma Co, will be following its current price history.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days YS Biopharma Co, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, YS Biopharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 271.1 M |
YS Biopharma |
YS Biopharma Relative Risk vs. Return Landscape
If you would invest 48.00 in YS Biopharma Co, on August 28, 2024 and sell it today you would earn a total of 0.00 from holding YS Biopharma Co, or generate 0.0% return on investment over 90 days. YS Biopharma Co, is generating negative expected returns and assumes 0.0% volatility on return distribution over the 90 days horizon. Put differently, 0% of stocks are less risky than YS Biopharma on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
YS Biopharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for YS Biopharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as YS Biopharma Co,, and traders can use it to determine the average amount a YS Biopharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| YS |
Based on monthly moving average YS Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of YS Biopharma by adding YS Biopharma to a well-diversified portfolio.
YS Biopharma Fundamentals Growth
YS Biopharma Stock prices reflect investors' perceptions of the future prospects and financial health of YS Biopharma, and YS Biopharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on YS Biopharma Stock performance.
| Return On Equity | -0.78 | |||
| Return On Asset | -0.1 | |||
| Profit Margin | (0.67) % | |||
| Operating Margin | (0.49) % | |||
| Current Valuation | 429.47 M | |||
| Shares Outstanding | 188.33 M | |||
| Price To Book | 2.10 X | |||
| Price To Sales | 0.29 X | |||
| Revenue | 687.2 M | |||
| EBITDA | (76.82 M) | |||
| Total Debt | 498.63 M | |||
| Book Value Per Share | 5.10 X | |||
| Cash Flow From Operations | (182.47 M) | |||
| Earnings Per Share | (0.56) X | |||
| Total Asset | 1.72 B | |||
| Retained Earnings | (1.87 B) | |||
About YS Biopharma Performance
Assessing YS Biopharma's fundamental ratios provides investors with valuable insights into YS Biopharma's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the YS Biopharma is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about YS Biopharma Co, performance evaluation
Checking the ongoing alerts about YS Biopharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for YS Biopharma Co, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| YS Biopharma Co, is now traded under the symbol LSB. Please update your portfolios or report it if you believe this is an error. Report It! | |
| YS Biopharma Co, is not yet fully synchronised with the market data | |
| YS Biopharma Co, has some characteristics of a very speculative penny stock | |
| YS Biopharma Co, has a very high chance of going through financial distress in the upcoming years | |
| The company generated the yearly revenue of 687.2 M. Annual Net Loss to common stockholders was (145.48 M) with gross profit of 0. | |
| YS Biopharma generates negative cash flow from operations | |
| About 81.0% of the company outstanding shares are owned by insiders |
- Analyzing YS Biopharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether YS Biopharma's stock is overvalued or undervalued compared to its peers.
- Examining YS Biopharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating YS Biopharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of YS Biopharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of YS Biopharma's stock. These opinions can provide insight into YS Biopharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in YS Biopharma Stock
If you are still planning to invest in YS Biopharma Co, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the YS Biopharma's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |